A case of anti-BP180 type mucous membrane pemphigoid successfully treated with intravenous immunoglobulin therapy

被引：0
|
作者：
Shiga, Takeo [1 ]
Aoki, Natsuko [1 ]
Nakajima, Kimiko [1 ]
Tarutani, Masahito [1 ]
Koga, Hiroshi [2 ]
Hashimoto, Takashi [2 ]
Sano, Shigetoshi [1 ]
机构：
[1] Kochi Univ, Dept Dermatol, Kochi Med Sch, Kochi, Japan
[2] Kurume Univ, Dept Dermatol, Sch Med, Inst Cutaneous Cell Biol, Kurume, Fukuoka, Japan
来源：
JOURNAL OF DERMATOLOGY | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [31] Bullous Pemphigoid Successfully Treated With a Combination Therapy of Plasmapheresis Followed by Intravenous High Dose Immunoglobulin
    Hattori, Yuki
    Takahashi, Tomoko
    Seishima, Mariko
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (04) : 421 - 423
  • [32] Study of original B cells producing pathogenic IgG and IgA autoantibodies in anti-BP180-type mucous membrane pemphigoid
    Hayashi, Daisuke
    Hashimoto, Takashi
    Mine, Mako
    Ishii, Norito
    Hashimoto, Koji
    Tsuchisaka, Atsunari
    Tsuruta, Daisuke
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (05)
  • [33] Pharyngeal obstruction due to hemorrhagic bullae in a patient with anti-BP180-type mucous membrane pemphigoid associated with acquired hemophilia A
    Seo, Seong Hoon
    Kim, Jong Hoon
    Hashimoto, Takashi
    Ishii, Norito
    Kim, Soo-Chan
    JOURNAL OF DERMATOLOGY, 2019, 46 (10): : E375 - E376
  • [34] Is anti-BP180 IgE associated with clinical phenotype? A reply to 'Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid'
    Amber, Kyle T.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2016, 308 (01) : 65 - 66
  • [35] Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: A preliminary study
    Daoud, Y
    Amin, KG
    Mohan, K
    Ahmed, AR
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (12) : 2003 - 2008
  • [36] Functional differences between pathogenic and nonpathogenic anti-BP180 antibodies in experimental bullous pemphigoid
    Rose, PA
    Liu, Z
    Diaz, LA
    Giudice, GJ
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 2437 - 2437
  • [37] Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients
    Di Zenzo, G
    Grosso, F
    Terracina, M
    Mariotti, F
    De Pità, O
    Owaribe, K
    Mastrogiacomo, A
    Sera, F
    Borradori, L
    Zambruno, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (01) : 103 - 110
  • [38] Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia
    Maki, Nobuki
    Demitsu, Toshio
    Umemoto, Naoka
    Nagashima, Kazutaka
    Nakamura, Toshinobu
    Kakurai, Maki
    Nakamura, Satoshi
    Yamada, Tomoko
    Ishii, Norito
    Hashimoto, Takashi
    JOURNAL OF DERMATOLOGY, 2016, 43 (05): : 571 - 574
  • [39] Mucosal substrates successfully identify the autoantigen in a case of mucous membrane pemphigoid
    Kamaguchi, Mayumi
    Iwata, Hiroaki
    Ujiie, Hideyuki
    Ohga, Noritaka
    Kitagawa, Yoshimasa
    Shimizu, Hiroshi
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (08): : 1032 - 1034
  • [40] Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy
    Sugawara, Nobuyuki
    Nagai, Yayoi
    Matsushima, Yoichiro
    Aoyama, Kumi
    Ishikawa, Osamu
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (06) : 1084 - 1089
12345